Michael A. Mathier

9.2k total citations · 3 hit papers
124 papers, 6.8k citations indexed

About

Michael A. Mathier is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michael A. Mathier has authored 124 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cardiology and Cardiovascular Medicine, 50 papers in Pulmonary and Respiratory Medicine and 38 papers in Surgery. Recurrent topics in Michael A. Mathier's work include Pulmonary Hypertension Research and Treatments (49 papers), Mechanical Circulatory Support Devices (33 papers) and Cardiovascular Function and Risk Factors (26 papers). Michael A. Mathier is often cited by papers focused on Pulmonary Hypertension Research and Treatments (49 papers), Mechanical Circulatory Support Devices (33 papers) and Cardiovascular Function and Risk Factors (26 papers). Michael A. Mathier collaborates with scholars based in United States, Japan and United Kingdom. Michael A. Mathier's co-authors include Victor F. Tapson, Vallerie V. McLaughlin, Myung H. Park, Michael D. McGoon, Harrison W. Farber, Lewis J. Rubin, David B. Badesch, Stephen L. Archer, Robyn J. Barst and Jonathan R. Lindner and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Michael A. Mathier

118 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2009 1.8k citations Vallerie V. McLaughlin, Stephen L. Archer et al. Journal of the American College of Cardiology profile →
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2009 844 citations Vallerie V. McLaughlin, Stephen L. Archer et al. Circulation profile →
The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure

1996 573 citations Michael A. Mathier, Marc J. Semigran et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Mathier United States	36	4.2k	3.9k	1.6k	831	729	124	6.8k
Stephan Rosenkranz Germany	54	5.6k 1.3×	5.2k 1.4×	1.3k 0.8×	346 0.4×	860 1.2×	267	10.0k
Stefano Ghio Italy	50	10.6k 2.5×	4.6k 1.2×	1.8k 1.1×	600 0.7×	1.2k 1.7×	256	12.4k
Evelyn M. Horn United States	36	2.9k 0.7×	3.1k 0.8×	760 0.5×	281 0.3×	429 0.6×	146	5.3k
David P. Jenkins United Kingdom	40	3.2k 0.8×	3.7k 1.0×	945 0.6×	566 0.7×	311 0.4×	163	6.4k
Philippe Hervé France	48	3.9k 0.9×	6.6k 1.7×	2.0k 1.2×	353 0.4×	1.1k 1.4×	131	8.9k
Angelo Branzi Italy	47	6.2k 1.5×	2.3k 0.6×	2.4k 1.5×	335 0.4×	1.2k 1.7×	307	9.1k
Ian Adatia Canada	43	3.3k 0.8×	6.0k 1.6×	2.3k 1.4×	600 0.7×	2.6k 3.6×	132	8.0k
Norifumi Nakanishi Japan	38	4.6k 1.1×	5.9k 1.5×	923 0.6×	161 0.2×	943 1.3×	116	7.7k
Vojtěch Melenovský Czechia	47	8.8k 2.1×	2.0k 0.5×	1.5k 0.9×	637 0.8×	700 1.0×	228	11.2k
Guillaume Jondeau France	50	5.8k 1.4×	4.2k 1.1×	1.6k 1.0×	403 0.5×	789 1.1×	255	9.3k

Countries citing papers authored by Michael A. Mathier

Since Specialization

Citations

This map shows the geographic impact of Michael A. Mathier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Mathier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Mathier more than expected).

Fields of papers citing papers by Michael A. Mathier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Mathier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Mathier. The network helps show where Michael A. Mathier may publish in the future.

Co-authorship network of co-authors of Michael A. Mathier

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Mathier. A scholar is included among the top collaborators of Michael A. Mathier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Mathier. Michael A. Mathier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iyanna, Nidhi, Ander Dorken‐Gallastegi, Michael A. Mathier, et al.. (2025). Mid-Term Reassessment of Waitlist and Posttransplant Outcomes Under the 2018 Heart Allocation System: Improved All-Cause Survival. Circulation Heart Failure. 18(10). e012663–e012663. 1 indexed citations

Frantz, Robert P., Shashank Desai, Gregory A. Ewald, et al.. (2024). SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation. Pulmonary Circulation. 14(4). e12446–e12446. 2 indexed citations

Hess, Nicholas R., Ander Dorken‐Gallastegi, Gavin Hickey, et al.. (2024). Association of agonal phase duration with heart utilization and post-transplant outcomes in donation after circulatory death heart transplantation. The Journal of Heart and Lung Transplantation. 44(5). 736–747. 3 indexed citations

Huckaby, Lauren V., Nicholas R. Hess, Gavin Hickey, et al.. (2024). Impact of post-transplant stroke and subsequent functional independence on outcomes following heart transplantation under the 2018 United States heart allocation system. The Journal of Heart and Lung Transplantation. 43(6). 878–888. 3 indexed citations

Seese, Laura, Ibrahim Sultan, Gavin Hickey, et al.. (2021). Pre-implant left ventricular dimension is not associated with worse outcomes after left ventricular assist device implantation. Journal of Thoracic Disease. 13(9). 5458–5466. 4 indexed citations

Rusiecki, Jennifer A., et al.. (2015). Sex and Menopause Differences in Response to Tadalafil: 6‐Minute Walk Distance and Time to Clinical Worsening. Pulmonary Circulation. 5(4). 701–706. 9 indexed citations

McLaughlin, Vallerie V., Seán Gaine, Luke Howard, et al.. (2013). Treatment Goals of Pulmonary Hypertension. Journal of the American College of Cardiology. 62(25). D73–D81. 213 indexed citations

Mathier, Michael A., et al.. (2010). Safety and Feasibility of Transitioning Stable Patients With Pulmonary Arterial Hypertension From Infused Treprostinil to Inhaled Treprostinil. CHEST Journal. 138(4). 369A–369A.

McLaughlin, Vallerie V., Stephen L. Archer, David B. Badesch, et al.. (2009). ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. Circulation. 119(16). 2250–2294. 844 indexed citations breakdown →

10.

Rajagopalan, Navin, Marc A. Simon, Kathy Edelman, Michael A. Mathier, & Angel López‐Candales. (2009). Identifying Left Ventricular Dysfunction in Pulmonary Hypertension. Congestive Heart Failure. 15(5). 218–221. 5 indexed citations

11.

Simon, Marc A., Christopher Deible, Michael A. Mathier, et al.. (2009). Phenotyping the Right Ventricle in Patients with Pulmonary Hypertension. Clinical and Translational Science. 2(4). 294–299. 36 indexed citations

12.

Toyoda, Yoshiya, Jnanesh Thacker, Ricardo Sales dos Santos, et al.. (2008). Long-Term Outcome of Lung and Heart-Lung Transplantation for Idiopathic Pulmonary Arterial Hypertension. The Annals of Thoracic Surgery. 86(4). 1116–1122. 59 indexed citations

13.

Ishizawar, David, Karen Janosko, J.J. Teuteberg, et al.. (2008). The ß1‐Adrenergic Receptor Mediates the Pharmacogenetic Interaction of the ACE D Allele and ß‐Blockers. Clinical and Translational Science. 1(2). 151–154. 1 indexed citations

14.

Mathier, Michael A., et al.. (2008). Dramatic Functional Improvement Following Bariatric Surgery in a Patient With Pulmonary Arterial Hypertension and Morbid Obesity. CHEST Journal. 133(3). 789–792. 18 indexed citations

15.

Tsukui, Hiroyuki, Adib A. Abla, Jeffrey J. Teuteberg, et al.. (2007). Cerebrovascular accidents in patients with a ventricular assist device. Journal of Thoracic and Cardiovascular Surgery. 134(1). 114–123. 87 indexed citations

16.

Banerjee, S., Ravi Ramani, Samir Saba, et al.. (2007). A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Biochemical and Biophysical Research Communications. 360(2). 381–387. 30 indexed citations

17.

Ramani, Ravi, Michael A. Mathier, Ping Wang, et al.. (2004). Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 287(3). H1369–H1377. 53 indexed citations

18.

Shannon, Richard P., et al.. (2000). Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs. Journal of the American College of Cardiology. 35(5). 1347–1354. 6 indexed citations

19.

Mathier, Michael A., Geoffrey Rose, Michael A. Fifer, et al.. (1998). Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 32(1). 216–224. 76 indexed citations

20.

Rose, Geoffrey, Michael A. Mathier, Sudhir S. Kushwaha, et al.. (1995). 786-3 Adenosine Causes Flow-Mediated Epicardial Vessel Dilation in Humans. Journal of the American College of Cardiology. 25(2). 336A–336A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact